Safety of JAK inhibitors: a real-life multicenter retrospective cohort study.

Marco Lanzillotta, Nicola Boffini, Elisa Barone, Gilberto Cincinelli,Maria Chiara Gerardi, Nicoletta Luciano,Maria Manara,Nicola Ughi,Oscar Massimiliano Epis,Carlo Selmi,Roberto Felice Caporali,Lorenzo Dagna

The Journal of rheumatology（2023）

引用 0|浏览21

暂无评分

摘要

Our real-life data confirm that JAKi are effective and carry a low risk of AESI, especially in patients that do not display cardiovascular risk factors at baseline. Our study could not identify differences between molecules and different profiles should be defined in larger prospective cohorts.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要